Literature DB >> 27001564

Definition of First-Line Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer.

Tomás Reinert1, Carlos H Barrios2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27001564     DOI： 10.1200/JCO.2015.66.0803

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Is progression-free survival a more relevant endpoint than overall survival in first-line HR+/HER2- metastatic breast cancer?

Authors:  Anna Forsythe; David Chandiwana; Janina Barth; Marroon Thabane; Johan Baeck; Anastasiya Shor; Gabriel Tremblay
Journal:  Cancer Manag Res       Date:  2018-05-04       Impact factor: 3.989

2.  Ribociclib for the first-line treatment of advanced hormone receptor-positive breast cancer: a review of subgroup analyses from the MONALEESA-2 trial.

Authors:  Gabriel N Hortobagyi
Journal:  Breast Cancer Res       Date:  2018-10-19       Impact factor: 6.466
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.